Table 3.
Exposed (n = 62) | Non Exposed (n = 50) | ||||||
---|---|---|---|---|---|---|---|
I Quartile | Median | III Quartile | I Quartile | Median | III Quartile | p-Value * | |
ADCYAP1 | 0.11 | 0.13 | 0.15 | 0.11 | 0.13 | 0.16 | 0.307 |
BDNF | 0.07 | 0.08 | 0.10 | 0.06 | 0.07 | 0.08 | 0.002 |
CRHR1 | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | 0.496 |
DRD2 | 0.10 | 0.14 | 0.17 | 0.08 | 0.11 | 0.14 | 0.003 |
FKBP5 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.018 |
IGF2 | 0.49 | 0.53 | 0.56 | 0.45 | 0.48 | 0.52 | 0.001 |
LSD1 | 0.04 | 0.04 | 0.05 | 0.03 | 0.04 | 0.06 | 0.186 |
NR3C1 | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 | 0.05 | 0.188 |
PRTFDC1 | 0.03 | 0.04 | 0.05 | 0.04 | 0.04 | 0.05 | 0.271 |
SLC6A4 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.347 |
* Non-parametric Wilcoxon rank-sum test (since Bonferroni’s correction for multiple comparisons is adopted, a p-value < 0.005 (0.05/10) indicates that the median is statistically different between groups). BDNF, DRD2, and IGF2 resulted in hypermethylated in trauma-exposed women.